Which document is listed as being located at both the investigator/institution and sponsor locations to reflect agreement on protocol/amendments and CRF?

Which document is listed as being located at both the investigator/institution and sponsor locations to reflect agreement on protocol/amendments and CRF?

• A. Investigator's Brochure
• B. Financial Aspects of the Trial
• C. Any Other Written Information
• D. Signed Protocol and Amendments if any, and Sample CRF

Answer: (A)

The main idea is keeping essential trial information accessible at both the sponsor and investigator sites so everyone is aligned on how the study will be conducted. The Investigator’s Brochure is the document that must be provided to investigators and kept at both locations. It contains current, comprehensive information about the investigational product, including safety data and the rationale for the protocol. When protocol amendments occur, they are reflected in the most recent IB, and copies are distributed so the investigator and sponsor share the same understanding of how the trial should be run and how data should be collected in the CRF. This shared access helps demonstrate that both parties are in agreement on the protocol and how data collection will be handled. The other documents either address different aspects (financials, generic written information) or, while important, are not the single document specifically maintained at both sites to reflect agreement on protocol changes and CRF usage in the same integrated way.

The main idea is keeping essential trial information accessible at both the sponsor and investigator sites so everyone is aligned on how the study will be conducted. The Investigator’s Brochure is the document that must be provided to investigators and kept at both locations. It contains current, comprehensive information about the investigational product, including safety data and the rationale for the protocol. When protocol amendments occur, they are reflected in the most recent IB, and copies are distributed so the investigator and sponsor share the same understanding of how the trial should be run and how data should be collected in the CRF. This shared access helps demonstrate that both parties are in agreement on the protocol and how data collection will be handled. The other documents either address different aspects (financials, generic written information) or, while important, are not the single document specifically maintained at both sites to reflect agreement on protocol changes and CRF usage in the same integrated way.